News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
670,959 Results
Type
Article (43087)
Company Profile (212)
Press Release (627660)
Multimedia
Podcasts (93)
Webinars (11)
Section
Business (189918)
Career Advice (2843)
Deals (35097)
Drug Delivery (117)
Drug Development (79155)
Employer Resources (168)
FDA (16304)
Job Trends (15536)
News (329061)
Policy (32088)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2746)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (91)
Alliances (47525)
ALS (99)
Alzheimer's disease (1444)
Antibody-drug conjugate (ADC) (132)
Approvals (16291)
Artificial intelligence (283)
Autoimmune disease (28)
Automation (16)
Bankruptcy (328)
Best Places to Work (12265)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (116)
Bladder cancer (81)
Brain cancer (28)
Breast cancer (288)
Cancer (2321)
Cardiovascular disease (192)
Career advice (2371)
Career pathing (33)
CAR-T (158)
Cell therapy (450)
Cervical cancer (18)
Clinical research (64458)
Collaboration (887)
Compensation (529)
Complete response letters (28)
COVID-19 (2600)
CRISPR (47)
C-suite (256)
Cystic fibrosis (106)
Data (2237)
Decentralized trials (2)
Denatured (25)
Depression (45)
Diabetes (281)
Diagnostics (6683)
Digital health (19)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (121)
Drug pricing (122)
Drug shortages (31)
Duchenne muscular dystrophy (97)
Earnings (75533)
Editorial (43)
Employer branding (21)
Employer resources (147)
Events (109951)
Executive appointments (764)
FDA (17578)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (769)
Gene editing (116)
Generative AI (24)
Gene therapy (331)
GLP-1 (773)
Government (4369)
Grass and pollen (5)
Guidances (56)
Healthcare (20074)
Huntington's disease (22)
IgA nephropathy (31)
Immunology and inflammation (131)
Indications (30)
Infectious disease (2750)
Inflammatory bowel disease (146)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (101)
Interviews (544)
IPO (16677)
IRA (48)
Job creations (3713)
Job search strategy (1974)
Kidney cancer (11)
Labor market (33)
Layoffs (488)
Leadership (24)
Legal (7544)
Liver cancer (68)
Lung cancer (324)
Lymphoma (153)
Machine learning (7)
Management (63)
Manufacturing (331)
MASH (72)
Medical device (14089)
Medtech (14094)
Mergers & acquisitions (19024)
Metabolic disorders (736)
Multiple sclerosis (83)
NASH (21)
Neurodegenerative disease (104)
Neuropsychiatric disorders (31)
Neuroscience (2013)
NextGen: Class of 2025 (6944)
Non-profit (4856)
Northern California (2719)
Now hiring (36)
Obesity (397)
Opinion (259)
Ovarian cancer (77)
Pain (97)
Pancreatic cancer (82)
Parkinson's disease (158)
Partnered (20)
Patents (247)
Patient recruitment (114)
Peanut (50)
People (56097)
Pharmaceutical (89)
Pharmacy benefit managers (21)
Phase I (20093)
Phase II (28473)
Phase III (21335)
Pipeline (1216)
Policy (157)
Postmarket research (2309)
Preclinical (8358)
Press Release (62)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (262)
Rare diseases (416)
Real estate (5653)
Recruiting (67)
Regulatory (22340)
Reports (29)
Research institute (2498)
Resumes & cover letters (455)
Rett syndrome (5)
RNA editing (4)
RSV (46)
Schizophrenia (77)
Series A (130)
Series B (87)
Service/supplier (11)
Sickle cell disease (58)
Southern California (2347)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (27)
Startups (3412)
State (2)
Stomach cancer (12)
Supply chain (75)
Tariffs (44)
The Weekly (66)
United States (23754)
Vaccines (671)
Venture capitalists (40)
Weight loss (276)
Women's health (30)
Worklife (19)
Date
Today (149)
Last 7 days (905)
Last 30 days (2754)
Last 365 days (34292)
2025 (11142)
2024 (36783)
2023 (41798)
2022 (52920)
2021 (57599)
2020 (56250)
2019 (49489)
2018 (37386)
2017 (33627)
2016 (32398)
2015 (37650)
2014 (28384)
2013 (23061)
2012 (24595)
2011 (25183)
2010 (22424)
Location
Africa (863)
Alabama (59)
Alaska (7)
Arizona (176)
Arkansas (13)
Asia (41023)
Australia (6887)
California (6220)
Canada (2030)
China (543)
Colorado (276)
Connecticut (290)
Delaware (153)
Europe (90579)
Florida (927)
Georgia (217)
Idaho (59)
Illinois (561)
India (26)
Indiana (325)
Iowa (10)
Japan (165)
Kansas (102)
Kentucky (26)
Louisiana (10)
Maine (70)
Maryland (896)
Massachusetts (4768)
Michigan (241)
Minnesota (397)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (25)
Nevada (65)
New Hampshire (69)
New Jersey (1775)
New Mexico (30)
New York (1775)
North Carolina (1037)
North Dakota (9)
Northern California (2719)
Ohio (213)
Oklahoma (14)
Oregon (38)
Pennsylvania (1394)
Puerto Rico (13)
Rhode Island (34)
South America (1221)
South Carolina (22)
South Dakota (1)
Southern California (2347)
Tennessee (103)
Texas (919)
Utah (191)
Virginia (158)
Washington D.C. (65)
Washington State (574)
West Virginia (3)
Wisconsin (59)
670,959 Results for "xspray pharma ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA Accepts Xspray Pharma’s NDA-resubmission for Dasynoc® – PDUFA Date set to 31 July 2024
Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY): The U.S. Food and Drug Administration (FDA) has accepted the resubmission of Xspray Pharma’s New Drug Application (NDA) for Dasynoc ® , following a Complete Response Letter (CRL) where additional information was requested.
February 12, 2024
·
2 min read
Press Releases
Notice to Annual General Meeting in AlzeCure Pharma AB
April 9, 2025
·
9 min read
Press Releases
Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission
September 19, 2024
·
2 min read
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) announced today the online publication of its abstract titled “Frequency of Comedication of Proton Pump Inhibitors with Crystalline Dasatinib in Chronic Myeloid Leukemia and Effects on TKI-Bioavailability” for presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 3rd, 2024 at 9-12 AM, Poster nr. 120 (1).
May 23, 2024
·
3 min read
Xspray Pharma’s XS003 Achieves Superior Bioavailability Milestone, Matching TASIGNA® at Reduced Dosage
Xspray Pharma AB announced that XS003, its amorphous, non-crystalline formulation of nilotinib, has demonstrated bioavailability within the 80-125% range to TASIGNA® following oral administration with significantly lower dose.
November 21, 2023
·
4 min read
Press Releases
Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors
April 22, 2025
·
2 min read
Press Releases
Nemysis Limited Announces Collaboration With Avia Pharma AB as IHAT Distributor in Nordic Region
March 14, 2025
·
2 min read
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
April 23, 2025
·
7 min read
1 of 67,096
Next
